"Reportedly, the company aggressively pursue pharmaceutical company in Southeast Asia as a step to the overseas business expansion," said the source told VIVAnews.com in Jakarta, Wednesday, July 13, 2011.
Director of Kalbe Farma, when asked for confirmation Vidjongtius admitted liability company plans to acquire pharmaceutical companies and goods for consumption. "Yes, we have planned acquisition of local and Asean," he told VIVAnews.com.
He added that currently, the company is in the process of exploration companies. "So, do not yet know the outcome," said Vidjong.
As for foreign companies that will purchase treasury stock, Kalbe, Vidjong said that until now there are companies that intend to buy.
As of May 31, 2011, PT Bina Artha Charisma own shares amounting to 8.01 percent KLBF coded, PT Gira Sole Prima (9.39 percent), PT Harvest Farm Ira (8.51 percent), PT Lucasta Murni Cemerlang (8.74 percent ), Diptanala PT Bahana (8.76 percent), PT Santa Seha Sanadi (8.88 percent), and UBS AG Singapore S / A PT Kalbe Farma Tbk as much as 7.69 percent. While the rest held by the public.
In trading Wednesday afternoon, KLBF Rp25 close higher (0.70 percent) to a level Rp3.550. PT Deutsche Securities Indonesia with DB code listed as the broker of the most widely collected Kalbe Farma shares.
As is known, the company set aside Rp500 billion to Rp1 trillion for the acquisition of local drug firms to raise revenues of about 15-18 percent this year.
Vidjongtius said, the funding comes from corporate action the company's internal cash. "We give priority to local companies. If possible could be expanded in scope to Asean," he said.
Kalbe Farma Acquisition of Foreign Drug Companies
This article
Kalbe Farma Acquisition of Foreign Drug Companies
can be opened in url
http://transportation22.blogspot.com/2011/08/kalbe-farma-acquisition-of-foreign-drug.html
Kalbe Farma Acquisition of Foreign Drug Companies
